Data as of Jan 28
| 0.00 / 0.00%|
The 4 analysts offering 12-month price forecasts for Synta Pharmaceuticals Corp have a median target of 14.00, with a high estimate of 27.00 and a low estimate of 1.00. The median estimate represents a +471.43% increase from the last price of 2.45.
The current consensus among 5 polled investment analysts is to Buy stock in Synta Pharmaceuticals Corp. This rating has held steady since January, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.